DZ Bank
TVRD

DZ Bank’s Tvardi Therapeutics TVRD Stock Holding History

DZ Bank’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,222
Closed -$990K – 1111
2018
Q1 		$990K Buy
+2,222
New +$1.08M ﹤0.01% 662

Other funds holding TVRD

RCP
Rho Capital Partners New York $20.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank's TVRD Position: Q2 2018 in Review

DZ Bank sold out of Tvardi Therapeutics (TVRD) in Q2 2018, closing a stake of 2,222 shares — an estimated $990K sold.

DZ Bank first reported a position in TVRD in Q1 2018 and held it in 1 quarter. The position peaked at $990K in Q1 2018. 130 funds tracked by Wall St. Rank hold TVRD as of Q2 2018.

  • DZ Bank reported no remaining Tvardi Therapeutics position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 2,222 Tvardi Therapeutics shares in Q2 2018, an estimated $990K.
  • DZ Bank first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 1 quarter.
  • DZ Bank's Tvardi Therapeutics position peaked at $990K in Q1 2018.
  • 130 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.